Respiri is an e-Health SaaS company supporting respiratory health management. Its world-first technology detects wheeze, a typical symptom of asthma, COPD and respiratory disease to provide an objective measure of airway limitation. wheezo, Respiri's innovative technology, comprises an eHealth app c... Respiri is an e-Health SaaS company supporting respiratory health management. Its world-first technology detects wheeze, a typical symptom of asthma, COPD and respiratory disease to provide an objective measure of airway limitation. wheezo, Respiri's innovative technology, comprises an eHealth app combined with a simple, easy to use, handheld device. wheezo is the first smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians, and other health care professionals. Respiri's mission is to help improve quality of life for hundreds of millions of children and adults around the world and dramatically reduce hospital admissions and the economic burden of asthma. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0581 | 0.0581 | 0.0581 | 3500 | 0.0581 | CS |
4 | 0.0024 | 4.30879712747 | 0.0557 | 0.0581 | 0.0546 | 253500 | 0.05462416 | CS |
12 | 0.0566 | 3773.33333333 | 0.0015 | 0.0581 | 0.0015 | 169000 | 0.05462416 | CS |
26 | 0.0566 | 3773.33333333 | 0.0015 | 0.0581 | 0.0015 | 72571 | 0.05451959 | CS |
52 | 0.05206 | 861.920529801 | 0.00604 | 0.0581 | 0.0015 | 68111 | 0.04689388 | CS |
156 | 0.0281 | 93.6666666667 | 0.03 | 0.06 | 0.0015 | 45647 | 0.04700187 | CS |
260 | 0.0281 | 93.6666666667 | 0.03 | 0.06 | 0.0015 | 45647 | 0.04700187 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관